• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌患者放疗引起的口干症

[Xerostomia caused by radiotherapy of patients with head and neck cancer].

作者信息

Bentzen J K

出版信息

Ugeskr Laeger. 1992 Jan 13;154(3):126-9.

PMID:1738952
Abstract

Xerostomia causes great inconvenience in patients treated with irradiation for cancer of the head and neck. For all practical purposes, salivary gland tissue becomes irreversibly incapable of functioning after doses of 40 Gy (standard fractioning). Curative doses are 60-70 Gy and, therefore, xerostomia can only be limited by attempting to involve as little as possible of salivary gland tissue in the irradiation fields. The limits of the tumour should be diagnosed as exactly as possible so that the irradiation fields are not made any larger than necessary "for safety". Therapeutic techniques which involve salivary gland tissue on only one side should be elected when this is justifiable. It is important to inform the patient about caries prohylaxis and the patient's own dentist should be involved in the problem as early as possible. Prophylatic fluorine treatment should be offered to alle of the patients.

摘要

口干给头颈部癌症放疗患者带来极大不便。实际上,给予40 Gy(标准分割剂量)后,唾液腺组织会不可逆地失去功能。根治性剂量为60 - 70 Gy,因此,只能通过尽量减少放疗野内唾液腺组织的照射来限制口干。应尽可能准确地诊断肿瘤边界,以使放疗野不会因“安全”因素而不必要地扩大。在合理的情况下,应选择仅累及一侧唾液腺组织的治疗技术。告知患者预防龋齿很重要,患者自己的牙医应尽早参与到这个问题中来。应为所有患者提供预防性氟治疗。

相似文献

1
[Xerostomia caused by radiotherapy of patients with head and neck cancer].头颈部癌患者放疗引起的口干症
Ugeskr Laeger. 1992 Jan 13;154(3):126-9.
2
Salivary gland sparing in the treatment of head and neck cancer.保留唾液腺在头颈部癌症治疗中的应用。
Expert Rev Anticancer Ther. 2011 Sep;11(9):1437-48. doi: 10.1586/era.11.101.
3
Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.利用技术减少接受放射治疗的头颈癌患者的口干症。
Semin Oncol. 2002 Dec;29(6 Suppl 19):71-9. doi: 10.1053/sonc.2002.37353.
4
Preventing radiation induced xerostomia.预防放射性口干症。
Cancer Treat Rev. 2005 Nov;31(7):546-54. doi: 10.1016/j.ctrv.2005.07.006. Epub 2005 Oct 26.
5
The prevention and treatment of radiotherapy - induced xerostomia.放射治疗引起的口干症的防治
Semin Radiat Oncol. 2003 Jul;13(3):302-8. doi: 10.1016/S1053-4296(03)00027-4.
6
A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.一项评估口服毛果芸香碱在头颈癌放疗期间及放疗后有效性的随机研究。
Anticancer Res. 2006 Mar-Apr;26(2B):1557-62.
7
Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.头颈部癌术后接受调强放射治疗患者皮下注射氨磷汀的毒性及依从性
Semin Oncol. 2004 Dec;31(6 Suppl 18):8-12. doi: 10.1053/j.seminoncol.2004.12.005.
8
Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.调强放射治疗在头颈部癌治疗中对下颌下腺的保护作用
Radiother Oncol. 2006 Mar;78(3):270-5. doi: 10.1016/j.radonc.2006.02.017. Epub 2006 Mar 27.
9
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.头颈部癌患者放疗所致口干症的评估、预防及管理
Curr Opin Oncol. 2006 May;18(3):266-70. doi: 10.1097/01.cco.0000219256.37843.83.
10
[Caries prevention in radiotherapy of the head-neck area].[头颈部放疗中的龋齿预防]
Laryngorhinootologie. 1992 Nov;71(11):561-3. doi: 10.1055/s-2007-997355.